emopamil has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Myrdal, PB; Simamora, P; Surakitbanharn, Y; Yalkowsky, SH | 1 |
| Drummond, JC; Fleischer, JE; Grafe, MR; Nakakimura, K; Scheller, MS; Shapiro, HM; Zornow, MH | 1 |
2 other study(ies) available for emopamil and Disease Models, Animal
| Article | Year |
|---|---|
Studies in phlebitis. VII: In vitro and in vivo evaluation of pH-solubilized levemopamil.
Topics: Animals; Buffers; Calcium Channel Blockers; Disease Models, Animal; Hydrogen-Ion Concentration; In Vitro Techniques; Mathematics; Models, Statistical; Pharmaceutical Preparations; Phlebitis; Rabbits; Time Factors; Verapamil | 1995 |
Effects of levemopamil on neurologic and histologic outcome after cardiac arrest in cats.
Topics: Animals; Blood Gas Analysis; Brain Ischemia; Cardiopulmonary Resuscitation; Cats; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Heart Arrest; Hemodynamics; Hippocampus; Infusions, Intravenous; Male; Neurologic Examination; Severity of Illness Index; Treatment Outcome; Verapamil | 1992 |